Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission.

Scicluna BP, Klein Klouwenberg PM, van Vught LA, Wiewel MA, Ong DS, Zwinderman AH, Franitza M, Toliat MR, Nürnberg P, Hoogendijk AJ, Horn J, Cremer OL, Schultz MJ, Bonten MJ, van der Poll T.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):826-35. doi: 10.1164/rccm.201502-0355OC.

PMID:
26121490
2.

Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.

Ugajin M, Yamaki K, Hirasawa N, Yagi T.

Respir Care. 2014 Apr;59(4):564-73. doi: 10.4187/respcare.02807. Epub 2013 Oct 29.

3.

Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.

Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A.

Crit Care Med. 2011 Oct;39(10):2211-7. doi: 10.1097/CCM.0b013e3182257445.

PMID:
21705887
4.

Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.

Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B.

Infection. 2005 Aug;33(4):257-63.

PMID:
16091896
5.

Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.

Le Bel J, Hausfater P, Chenevier-Gobeaux C, Blanc FX, Benjoar M, Ficko C, Ray P, Choquet C, Duval X, Claessens YE; ESCAPED study group.

Crit Care. 2015 Oct 16;19:366. doi: 10.1186/s13054-015-1083-6.

6.

Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP).

Tamura M, Watanabe M, Nakajima A, Kurai D, Ishii H, Takata S, Nakamoto K, Sohara E, Honda K, Nakamura M, Inui T, Wada H, Takizawa H, Goto H.

J Infect Chemother. 2014 Feb;20(2):97-103. doi: 10.1016/j.jiac.2013.09.005. Epub 2013 Dec 11.

PMID:
24462441
7.

Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.

Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P; ProHOSP Study Group.

Clin Chem Lab Med. 2015 Mar;53(4):559-66.

PMID:
25014522
8.

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.

España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.

J Infect. 2015 May;70(5):457-66. doi: 10.1016/j.jinf.2014.12.003. Epub 2014 Dec 11.

PMID:
25499199
9.

Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.

Que YA, Delodder F, Guessous I, Graf R, Bain M, Calandra T, Liaudet L, Eggimann P.

Crit Care. 2012 Jul 2;16(4):R114. doi: 10.1186/cc11406.

10.

Comprehensive Validation of the FAIM3:PLAC8 Ratio in Time-matched Public Gene Expression Data.

Sweeney TE, Khatri P.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1260-1. doi: 10.1164/rccm.201507-1321LE. No abstract available.

11.

FAIM3:PLAC8 Ratio Compared with Existing Biomarkers for Diagnosis of Severe Community-acquired Pneumonia: Comparing Apples to Oranges?

Narasimhan RL, Agarwal R, Sehgal IS.

Am J Respir Crit Care Med. 2016 Jan 1;193(1):101-2. doi: 10.1164/rccm.201508-1630LE. No abstract available.

PMID:
26720791
12.

Reply: Comprehensive Validation of the FAIM3:PLAC8 Ratio in Time-matched Public Gene Expression Data.

Scicluna BP, Klein Klouwenberg PM, van der Poll T; all the authors.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1261-2. doi: 10.1164/rccm.201508-1552LE. No abstract available.

PMID:
26568248
13.

Reply: FAIM3:PLAC8 Ratio Compared with Existing Biomarkers for Diagnosis of Severe Community-acquired Pneumonia: Comparing Apples to Oranges?

Scicluna BP, van Vught LA, van der Poll T, Klein Klouwenberg PM, Cremer OL.

Am J Respir Crit Care Med. 2016 Jan 1;193(1):102-3. doi: 10.1164/rccm.201509-1752LE. No abstract available.

PMID:
26720792
14.

The value of procalcitonin level in community-acquired pneumonia in the ED.

Park JH, Wee JH, Choi SP, Oh SH.

Am J Emerg Med. 2012 Sep;30(7):1248-54. doi: 10.1016/j.ajem.2011.08.009. Epub 2011 Oct 24.

PMID:
22030193
15.

Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia.

Labarère J, Schuetz P, Renaud B, Claessens YE, Albrich W, Mueller B.

Acad Emerg Med. 2012 Sep;19(9):993-1003. doi: 10.1111/j.1553-2712.2012.01424.x.

16.

Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.

Piacentini E, Sánchez B, Arauzo V, Calbo E, Cuchi E, Nava JM.

J Crit Care. 2011 Apr;26(2):201-5. doi: 10.1016/j.jcrc.2010.07.009. Epub 2010 Sep 1.

PMID:
20813489
17.

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M.

BMC Infect Dis. 2007 Mar 2;7:10.

18.

Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.

Lindstrom ST, Wong EK.

Intern Med J. 2014 Apr;44(4):390-7. doi: 10.1111/imj.12374.

PMID:
24528892
19.
20.

Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.

Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, Mensa J, Luque N, Ewig S, Menendez R, Niederman MS, Torres A.

Clin Infect Dis. 2009 Feb 15;48(4):377-85. doi: 10.1086/596307.

PMID:
19140759

Supplemental Content

Support Center